Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTrav in Patients Previously Uncontrolled on a Beta-blocker

Trial Profile

Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTrav in Patients Previously Uncontrolled on a Beta-blocker

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Aug 2016

At a glance

  • Drugs Travoprost/timolol (Primary) ; Travoprost/timolol (Primary) ; Beta-adrenergic receptor antagonists; Beta-adrenergic receptor antagonists
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 26 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 28 Apr 2015 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Apr 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top